# Citius Oncology, Inc.: Form 8-K, filed Sep 29, 2026

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: 8-K
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 29, 2026, 16:30 ET
- Period: 2026-09-29
- Accession: 0001213900-26-104694
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000121390026104694/ea0307034-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000121390026104694/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000121390026104694/ea0307034-8k_citius.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-104694. Last ingested by Listed: Nov 14, 2026, 21:33 ET. No prices; not investment advice.
